Preconference preliminary program - March 13

Wednesday March 13

7:30 - 8:30

Registration – Vanity Fair Foyer 2nd floor
Breakfast – Palm Mall & Palm Court

8:30 - 8:40

Welcome from C3i – Centre for Commercialization of Cancer Immunotherapy

Lambert Busque, Chief Medical Officer, C3i

Vanity Fair Ballroom 

Theme 1: The role of biomarkers in supporting GMP manufacturing 

Vanity Fair Ballroom

8:40 - 10:10

Approaches used to set specifications for release of cell and gene therapy product
Speaker to be confirmed 

Characterizing products for GMP manufacturing: What, how and when?
Donna Rill
, Chief Technology Officer, Triumvira Immunologics

Analytical testing: preparing for the jump from research lab to GMP manufacturing
Martin Giroux
, CETC, Montréal

Ensuring the quality of regenerative medicine: recommendations from the Forum on Regenerative Medicine by the National Academies of Sciences, Engineering and Medicine

Regulatory requirements for cell therapy release criteria in Canada
Speaker to be confirmed

 

10:10 - 10:40

Panelist discussion: Regulatory requirements for cell therapy release criteria

10:40 - 11:00

Health break and exhibitors visit 

11:10 - 12:10

Introduction to novel technologies for biomarker discovery and tracking

Sponsored talk 1
Sponsored talk 2
Sponsored talk 3
Sponsored talk 4

12:10 - 13:30

Lunch, networking and exhibitors visit

Vanity Fair Ballroom

Theme 2: Clinical response to CAR Ts and other cellular therapies

Chair: To be confirmed

Vanity Fair Ballroom

13:30 - 15:00

Characterizing the response to cellular therapies with immunophenotyping 
Jean-Sébastien Delisle
, MD, PhD, C3i/HMR

Determinants of response and resistance in CAR T cell therapy
Andreas Bader
, PhD, Senior Vice President R&D, Triumvira Immunologics

CAR T cell fitness and its impact on potency and persistence
Speakers to be confirmed

Exploring the importance of CAR T cell trafficking and control
Speakers to be confirmed

Strategies to increase efficacy of cellular therapies in solid tumors
Speakers to be confirmed

15:00 - 15:30

Health break and exhibitors visit

Theme 3 - Companion tests and patient stratification in the era of personalized medicine

Chair: Lambert Busque, Chief Medical Officer, C3i

Vanity Fair Ballroom

15:30 - 17:00

Pharma / diagnostic partnership in companion diagnostics development
Speakers to be confirmed

Preanalytical variable standards for liquid biopsies
Speakers to be confirmed

The use of models for response prediction
Speakers to be confirmed

Integration of companion tests in the public health care system
Lambert Busque, MD, FRPCP, Chief medical officer, C3i

17:00 - 17:10

Closing remarks of the preconference

Lambert Busque, Chief Medical Officer, C3i

Vanity Fair Ballroom

17:10 - 20:00

Networking Cocktail & Welcome Reception of the Main conference

Exhibition Hall